Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands-Reference-Cited by-同舟云学术

Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands

Published:2013-02-27 Issue:5 Volume:56 Page:2139-2149
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Mosberg Henry I.¹²,Yeomans Larisa¹,Harland Aubrie A.²,Bender Aaron M.²,Sobczyk-Kojiro Katarzyna¹,Anand Jessica P.²,Clark Mary J.³,Jutkiewicz Emily M.³,Traynor John R.³

Affiliation:

1. Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States

2. Interdepartmental Program in Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States

3. Department of Pharmacology, Medical School, University of Michigan, Ann Arbor, Michigan 48109, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm400050y

Reference36 articles.

1. Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges